Nevertheless, in response to certain chronic inflammatory conditions (e.g., specific cancers and viral infections), our findings indicate that specifically targeting LPA5 signaling within secondary lymphoid organs could enhance activation of a broader repertoire of CD8 T cells to promote a more effective immune response. This evidence concerns the gene CD8A and viral infectious disease.